This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Ariceum Therapeutics Gmbh. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2025
Title: The Innovations of Joel Richard
Introduction
Joel Richard is an accomplished inventor based in Dreux, France. He has made significant contributions to the field of radiopharmaceuticals, holding a total of 2 patents. His work focuses on the development of somatostatin analogue compositions, which have important applications in both diagnostic and therapeutic settings.
Latest Patents
Joel Richard's latest patents include a composition containing a somatostatin analogue for radiopharmaceutical use. This invention specifically relates to a receptor-selective somatostatin peptide antagonist, which is designed for diagnostic or therapeutic applications. The innovative nature of this composition highlights the potential for advancements in medical imaging and treatment options.
Career Highlights
Throughout his career, Joel Richard has demonstrated a commitment to advancing medical technology. His work at Ariceum Therapeutics GmbH has positioned him as a key player in the development of novel therapeutic solutions. His expertise in somatostatin analogues showcases his dedication to improving patient outcomes through innovative research.
Collaborations
Joel has collaborated with notable colleagues, including Anne Petit and Didier Nourrisson. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their work in the field.
Conclusion
In summary, Joel Richard is a prominent inventor whose contributions to radiopharmaceuticals are noteworthy. His innovative patents and collaborative efforts reflect his dedication to advancing medical science. His work continues to pave the way for future developments in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile